Screener
Guardian Pharmacy Services GRDN Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Guardian Pharmacy Services in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Guardian Pharmacy Services’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338074
FAQ
- What is Guardian Pharmacy Services's cash & equivalents?
- Guardian Pharmacy Services (GRDN) reported cash & equivalents of $89.81M in Q2 2026.
- How has Guardian Pharmacy Services's cash & equivalents changed year-over-year?
- Guardian Pharmacy Services's cash & equivalents increased by 377.3% year-over-year, from $18.82M to $89.81M.
- What is the long-term trend for Guardian Pharmacy Services's cash & equivalents?
- Over 2 years (2023 to 2025), Guardian Pharmacy Services's cash & equivalents has grown at a 834.1% compound annual growth rate (CAGR), from $752K to $65.62M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Guardian Pharmacy Services's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude